Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients
Status:
Withdrawn
Trial end date:
2018-07-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the intestinal flora in subjects with
Parkinson's Disease (PD) and to determine safety and trends in improvements in diversity of
colonic microbiome following fecal microbiota transplantation.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston